XML 35 R24.htm IDEA: XBRL DOCUMENT v3.8.0.1
SEGMENT AND ENTERPRISE-WIDE INFORMATION (Tables)
9 Months Ended
Dec. 30, 2017
Segment Reporting [Abstract]  
Selected Information by Business Segment
Selected information by business segment is presented below:
 
Three Months Ended
 
Nine Months Ended
(In thousands)
December 30,
2017
 
December 31,
2016
 
December 30,
2017
 
December 31,
2016
Net revenues
 
 
 
 
 
 
 
Japan
$
18,161

 
$
20,173

 
$
50,557

 
$
53,730

EMEA
47,481

 
49,857

 
134,275

 
141,531

North America Plasma
86,545

 
83,324

 
249,132

 
235,091

All Other
83,717

 
79,884

 
242,084

 
236,315

Net revenues before foreign exchange impact
235,904

 
233,238

 
676,048

 
666,667

Effect of exchange rates
(1,861
)
 
(5,397
)
 
(5,677
)
 
(8,617
)
Net revenues
$
234,043

 
$
227,841

 
$
670,371

 
$
658,050

 
Three Months Ended
 
Nine Months Ended
(In thousands)
December 30,
2017
 
December 31,
2016
 
December 30,
2017
 
December 31,
2016
Segment operating income
 
 
 
 
 
 
 
Japan
$
8,967

 
$
9,514

 
$
23,582

 
$
24,687

EMEA
11,423

 
11,143

 
28,233

 
27,996

North America Plasma
31,740

 
23,125

 
88,026

 
74,443

All Other
31,551

 
27,422

 
89,289

 
85,538

Segment operating income
83,681

 
71,204

 
229,130

 
212,664

  Corporate operating expenses
(44,608
)
 
(36,339
)
 
(126,824
)
 
(124,398
)
  Effect of exchange rates
2,755

 
(151
)
 
1,656

 
(790
)
Restructuring and turnaround costs
(31,298
)
 
(6,762
)
 
(39,568
)
 
(27,215
)
Deal amortization
(6,506
)
 
(6,530
)
 
(19,501
)
 
(20,611
)
Legal charges
(3,011
)
 

 
(3,011
)
 

Asset impairments

 
(210
)
 

 
(1,525
)
Operating income
$
1,013

 
$
21,212

 
$
41,882

 
$
38,125

Schedule of Revenues by Product Line and Geographic Regions
Net revenues by business unit are as follows:
 
Three Months Ended
Nine Months Ended
(In thousands)
December 30,
2017
 
December 31,
2016
 
December 30, 2017
 
December 31, 2016
Plasma
$
113,098

 
$
108,655

 
$
324,376

 
$
309,868

Blood Center
74,227

 
76,354

 
211,502

 
221,567

Cell Processing
26,829

 
25,918

 
78,929

 
77,949

Hemostasis Management
19,889

 
16,914

 
55,564

 
48,666

Net revenues
$
234,043

 
$
227,841

 
$
670,371

 
$
658,050

Net revenues generated in our principle operating regions on a reported basis are as follows:
 
Three Months Ended
 
Nine Months Ended
(In thousands)
December 30,
2017
 
December 31,
2016
 
December 30,
2017
 
December 31,
2016
United States
$
140,840

 
$
136,759

 
$
410,671

 
$
393,302

Japan
17,664

 
22,319

 
49,312

 
58,949

Europe
42,189

 
38,892

 
118,544

 
116,865

Asia
30,733

 
27,749

 
85,504

 
83,125

Other
2,617

 
2,122

 
6,340

 
5,809

Net revenues
$
234,043

 
$
227,841

 
$
670,371

 
$
658,050